These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2012-005287-10 A Phase III Double-blinded, Placebo Controlled Study of Xilonix? for Improving Survival in Metastatic Colorectal Cancer Estudio de fase III, doble ciego, controlado con placebo de Xilonix? para la... 2017-07-07 due-trials
Reported results 2014-000550-12 A Double Blind, Placebo Controlled, Pivotal Phase III Study Evaluating Xilonix™ in Symptomatic Colorectal Cancer Patients Refractory To Standard Therapy 2017-10-12 due-trials
Exempt 2015-003510-25 A Phase I-II Study of the Safety and Efficacy of a True Human Antibody, 514G3, in Subjects Hospitalized with Bacteremia Due to Staphylococcus Aureus Eine Phase-I-II-Studie über die Sicherheit und ... 2017-03-27 not-yet-due